# Filing Detail

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001104659-20-091817
Filing Date
2020-08-07
Accepted
2020-08-07 10:06:05
Documents
74

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | F-1/A | tm2016252-15_f1a.htm | F-1/A | 5154648
2 | EXHIBIT 3.1 | tm2016252d8_ex3-1.htm | EX-3.1 | 284255
3 | EXHIBIT 4.1 | tm2016252d17_ex4-1.htm | EX-4.1 | 168587
4 | EXHIBIT 10.38 | tm2016252d17_ex10-38.htm | EX-10.38 | 76897
5 | EXHIBIT 10.39 | tm2016252d17_ex10-39.htm | EX-10.39 | 35408
6 | EXHIBIT 10.40 | tm2016252d17_ex10-40.htm | EX-10.40 | 31049
7 | EXHIBIT 23.1 | tm2016252d15_ex23-1.htm | EX-23.1 | 3557
8 | EXHIBIT 99.8 | tm2016252d17_ex99-8.htm | EX-99.8 | 3035
9 | EXHIBIT 99.9 | tm2016252d17_ex99-9.htm | EX-99.9 | 2641
10 | EXHIBIT 99.10 | tm2016252d17_ex99-10.htm | EX-99.10 | 2675
11 | EXHIBIT 99.11 | tm2016252d17_ex99-11.htm | EX-99.11 | 3530
12 | EXHIBIT 99.12 | tm2016252d17_ex99-12.htm | EX-99.12 | 3429
13 | GRAPHIC | lg_curevacfpo-4clr.jpg | GRAPHIC | 40504
14 | GRAPHIC | tm2016252d6-fc_product4clr.jpg | GRAPHIC | 163875
15 | GRAPHIC | tm2016252d6_riderbofa42820.jpg | GRAPHIC | 387706
16 | GRAPHIC | tm2016252d6_fc-transfpo4c.jpg | GRAPHIC | 512034
17 | GRAPHIC | tm2016252d6_fc-bodyfpo4c.jpg | GRAPHIC | 394911
18 | GRAPHIC | tm2016252d6_fc-rnaooptfpo.jpg | GRAPHIC | 188317
19 | GRAPHIC | tm2016252d6_fc-exploongfpo.jpg | GRAPHIC | 223595
20 | GRAPHIC | tm2016252d6_lc-halffpo4c.jpg | GRAPHIC | 496744
21 | GRAPHIC | tm2016252d6_lc-half2fpo4c.jpg | GRAPHIC | 148797
22 | GRAPHIC | tm2016252d6_lc-prodesfpo4c.jpg | GRAPHIC | 103023
23 | GRAPHIC | tm2016252d6_fc-prodesfpo4c.jpg | GRAPHIC | 188729
24 | GRAPHIC | tm2016252d6_lc-modimfpo4c.jpg | GRAPHIC | 125271
25 | GRAPHIC | tm2016252d6_fc-sequence4c.jpg | GRAPHIC | 167979
26 | GRAPHIC | tm2016252d6-mrna.jpg | GRAPHIC | 161398
27 | GRAPHIC | tm2016252d6_bc-activfpo4c.jpg | GRAPHIC | 229630
28 | GRAPHIC | tm2016252d6-successive.jpg | GRAPHIC | 274950
29 | GRAPHIC | tm2016252d6_bc-optutrfpo4c.jpg | GRAPHIC | 117502
30 | GRAPHIC | tm2016252d6_bc-optorffpo4c.jpg | GRAPHIC | 160928
31 | GRAPHIC | tm2016252d6_bc-opt3endfpo4c.jpg | GRAPHIC | 137075
32 | GRAPHIC | tm2016252d6-diverse.jpg | GRAPHIC | 218699
33 | GRAPHIC | tm2016252d6_sc-vaclpnfpo.jpg | GRAPHIC | 303470
34 | GRAPHIC | tm2016252d6_sc-cvcmfpo4c.jpg | GRAPHIC | 179561
35 | GRAPHIC | tm2016252d6-cvcm.jpg | GRAPHIC | 135676
36 | GRAPHIC | tm2016252d6-production.jpg | GRAPHIC | 127751
37 | GRAPHIC | tm2016252d6_ph-buildfpo4c.jpg | GRAPHIC | 2379805
38 | GRAPHIC | tm2016252d6_ph-curevac4clr.jpg | GRAPHIC | 1604041
39 | GRAPHIC | tm2016252d6-ph_tumor4clr.jpg | GRAPHIC | 616245
40 | GRAPHIC | tm2016252d6-tbl_prelim4clr.jpg | GRAPHIC | 596008
41 | GRAPHIC | tm2016252d6-fc_cohorts4clr.jpg | GRAPHIC | 684971
42 | GRAPHIC | tm2016252d6-tbl_prefer4clr.jpg | GRAPHIC | 571212
43 | GRAPHIC | tm2016252d6-bc_prelim4clr.jpg | GRAPHIC | 2141159
44 | GRAPHIC | tm2016252d6_ph-melanfpo4c.jpg | GRAPHIC | 250665
45 | GRAPHIC | tm2016252d6-ph_lesions4clr.jpg | GRAPHIC | 279473
46 | GRAPHIC | tm2016252d6_ph-metafpo4c.jpg | GRAPHIC | 199853
47 | GRAPHIC | tm2016252d6_ph-pretrefpo4c.jpg | GRAPHIC | 130174
48 | GRAPHIC | tm2016252d6_lc-survfpo4c.jpg | GRAPHIC | 197463
49 | GRAPHIC | tm2016252d6_lc-tumorfpo4c.jpg | GRAPHIC | 152552
50 | GRAPHIC | tm2016252d6_lc-tumor2fpo4c.jpg | GRAPHIC | 180661
51 | GRAPHIC | tm2016252d6_lc-abscofpo4c.jpg | GRAPHIC | 179721
52 | GRAPHIC | tm2016252d6_fc-dosek.jpg | GRAPHIC | 168274
53 | GRAPHIC | tm2016252-6_riderg42820.jpg | GRAPHIC | 135900
54 | GRAPHIC | tm2016252d6-lc_cv72024c.jpg | GRAPHIC | 483505
55 | GRAPHIC | tm2016252d6-bc_sars4clr.jpg | GRAPHIC | 201098
56 | GRAPHIC | tm2016252d6-bc_induc4clr.jpg | GRAPHIC | 528620
57 | GRAPHIC | tm2016252d6-bc_kinet4clr.jpg | GRAPHIC | 993673
58 | GRAPHIC | tm2016252-6_riderf42820.jpg | GRAPHIC | 40922
59 | GRAPHIC | tm2016252d6_lc-influenfpo4c.jpg | GRAPHIC | 384598
60 | GRAPHIC | tm2016252d6_bc-servntfpoo4c.jpg | GRAPHIC | 317224
61 | GRAPHIC | tm2016252d6_bc-lungfpoo4c.jpg | GRAPHIC | 250006
62 | GRAPHIC | tm2016252d6_fc-liverfpo4c.jpg | GRAPHIC | 124269
63 | GRAPHIC | tm2016252d6_sc-25hcfpo4c.jpg | GRAPHIC | 178879
64 | GRAPHIC | tm2016252d6_fc-therafpo4c.jpg | GRAPHIC | 726221
65 | GRAPHIC | tm2016252d6_lc-aminofpo4c.jpg | GRAPHIC | 171145
66 | GRAPHIC | tm2016252d6_ph-ccl4fpo4c.jpg | GRAPHIC | 551026
67 | GRAPHIC | tm2016252d6_lc-dfpo4c.jpg | GRAPHIC | 74949
68 | GRAPHIC | tm2016252d6_lc-gfpo4c.jpg | GRAPHIC | 83627
69 | GRAPHIC | tm2016252d6_lc-rituxfpo4c.jpg | GRAPHIC | 115145
70 | GRAPHIC | tm2016252d6_fc-retinafpo4c.jpg | GRAPHIC | 277281
71 | GRAPHIC | tm2016252d6_sc-areabuff.jpg | GRAPHIC | 636142
72 | GRAPHIC | tm2016252d6_bc-levelsfpo4c.jpg | GRAPHIC | 185529
73 | GRAPHIC | lg_curevac-fpo.jpg | GRAPHIC | 79401
74 | GRAPHIC | tm2016252d17_10xxxximg01.jpg | GRAPHIC | 3807
| Complete submission text file | 0001104659-20-091817.txt |  | 35746293

Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac B.V. (Filer) CIK: 0001809122 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-240076 | Film No.: 201084135
SIC: 2834 Pharmaceutical Preparations